IOF President's Award presented to osteoporosis experts from 7 regions of the world

March 28, 2015

In a special presentation on March 27, 2015 at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, the International Osteoporosis Foundation (IOF) recognized the outstanding contributions of seven individuals from different regions of the world.

The IOF President's Award is presented to IOF members who have shown noteworthy and long-term dedication to the work of IOF and to the advancement of osteoporosis awareness and education worldwide.

The winners, selected from each of seven geographical regions, are:

ASIA-PACIFIC - Professor Liu Zhonghou, President and CNS representative of the Osteoporosis Committee of China Gerontological Society, Honorary Treasurer and Board member of the Asia Pacific Osteoporosis Foundation, Editor-in-chief of the Chinese Journal of Osteoporosis.

EASTERN EUROPE - Professor Edward Czerwinski, Head Bone and Joint Diseases Department, Medical College of the Jagiellonian University, Krakow, Poland, CNS representative of the Polish Osteoarthrology Society.

SOUTHERN EUROPE - Professor Sansin Tüzün, Istanbul University, Cerrahpasa School of Medicine and Chair of the Department of Physical Medicine and Rehabilitation, CNS representative of the Osteoporosis Patient Society of Turkey.

WESTERN EUROPE - Professor Marius Kraenzlin, Consultant of Calcium and Bone Metabolism, Clinic for Endocrinology, Diabetology and Metabolism, University of Basel, Past CNS representative Swiss Society against Osteoporosis, Member the IOF Committee of Scientific Advisors, Member IOF CSA Bone & Diabetes Working Group.

MIDDLE EAST & AFRICA - Dr Gemma Adib, Founder and President of the Syrian National Osteoporosis Society (SYNOS); past President and former General Secretary of the Pan Arab Osteoporosis Society (PAOS); Board Member of IOF representing the Middle East and Africa region and Chair of the IOF Middle East & Africa Regional Advisory Council (RAC).

LATIN AMERICA - Dr Cristiano Zerbini, Founding Director Centro Paulista de Investigação Clinica (CEPIC), Member IOF Board of Governance, CNS representative of the Brazilian Society of Osteoporosis (SOBRAO); Member of the IOF Board, Latin American Regional Advisory Committee, and Chair of the Inflammation and Bone Architecture Working Group.

NORTH AMERICA - Dr Mike McClung, Founding Director Oregon Osteoporosis Center, Founding Director Oregon Osteoporosis Center, Member IOF Committee of Scientific Advisors, Member of Menopausal Hormone Therapy and Bone Markers IOF Working Groups.

IOF President Professor John A. Kanis stated, "We are honoured to recognize the outstanding contributions of these IOF members, who are all leading osteoporosis experts in their countries and regions. This Award recognizes their efforts as educators and advocates for fracture prevention and improved osteoporosis patient care. Thanks to their work, public awareness and health professional knowledge of osteoporosis has grown immensely over the past decade in all regions of the world."
About the World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases:

Held jointly by IOF and ESCEO, the Congress is taking place in Milan, Italy from March 26-29, 2015. It is the world's largest annual forum for the presentation of clinical research and new advances in the prevention and management of bone, muscle and joint disorders. The next Congress will be held in Malaga, Spain from April 14-17, 2016. For complete information visit the WCO IOF-ESCEO 2015 website #OsteoCongress

About IOF

The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers, leading companies, as well as more than 200 patient, medical and research societies, work together to make bone, joint and muscle health a worldwide heath care priority.;;

International Osteoporosis Foundation

Related Osteoporosis Articles from Brightsurf:

New opportunities for detecting osteoporosis
Osteoporosis can be detected through low dose computed tomography (LDCT) imaging tests performed for lung cancer screening or other purposes.

Oxytocin can help prevent osteoporosis
In a laboratory experiment with rats, Brazilian researchers succeeded in reversing natural processes associated with aging that lead to loss of bone density and strength.

New strategy against osteoporosis
An international research team has found a new approach that may be able to reduce bone loss in osteoporosis and maintain bone health.

New review on management of osteoporosis in premenopausal women
An IOF and ECTS Working Group have published an updated review of literature published after 2017 on premenopausal osteoporosis.

Cardiac CT can double as osteoporosis test
Cardiac CT exams performed to assess heart health also provide an effective way to screen for osteoporosis, potentially speeding treatment to the previously undiagnosed, according to a new study.

Osteoporosis treatment may also protect against pneumonia
A recent study published in the Journal of Bone and Mineral Research found that nitrogen-containing bisphosphonates (N-BPs) such as alendronate, which are widely used to treat postmenopausal osteoporosis, are linked with lower risks of pneumonia and of dying from pneumonia.

New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.

A link between mitochondrial damage and osteoporosis
In healthy people, a tightly controlled process balances out the activity of osteoblasts, which build bone, and osteoclasts, which break it down.

Many stroke patients not screened for osteoporosis, despite known risks
Many stroke survivors have an increased risk of osteoporosis, falls or breaks when compared to healthy people.

Many postmenopausal women do not receive treatment for osteoporosis
The benefits of treating osteoporosis in postmenopausal women outweigh the perceived risks, according to a Clinical Practice Guideline issued today by the Endocrine Society.

Read More: Osteoporosis News and Osteoporosis Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to